PNC-27 Peptide: A Breakthrough in Targeted Cancer Therapeutics
Discover the advanced capabilities of PNC-27, a synthetic, membrane-active peptide designed for highly selective cancer treatment. As a leading supplier, we offer this innovative compound to researchers and pharmaceutical developers worldwide.
Get a Quote & SampleRevolutionary Peptide for Precision Oncology
PNC-27 Peptide
NINGBO INNO PHARMCHEM CO.,LTD. is proud to be a premier manufacturer and supplier of PNC-27, a synthetic anti-cancer peptide. Our commitment to quality ensures that researchers can rely on us for high-purity active pharmaceutical ingredients. Explore the efficacy of PNC-27 in inducing tumor cell necrosis.
- Targeted Cancer Cell Death: PNC-27 selectively binds to the HDM-2 protein on cancer cell membranes, initiating membranolysis for precise tumor cell destruction.
- P53-Independent Mechanism: This synthetic peptide's effectiveness is not reliant on p53 activation, broadening its applicability in diverse cancer types.
- High Purity & Quality: As a dedicated supplier in China, we guarantee the highest standards for our PNC-27 peptide, supporting critical research and development efforts.
- Minimizing Healthy Tissue Damage: The targeted action of PNC-27 ensures minimal impact on surrounding healthy cells, a significant advantage over traditional therapies.
Key Advantages of PNC-27
Selective Tumor Necrosis
PNC-27 induces pore formation in cancer cell membranes, leading to necrosis and effectively targeting tumor cells. This mechanism is crucial for developing novel cancer treatments.
Broad Applicability
Our PNC-27 peptide demonstrates efficacy against various cancer cell lines, including those resistant to conventional chemotherapy, making it a versatile agent for research and therapeutic exploration.
Advanced Research Support
As a reliable manufacturer and supplier of pharmaceutical intermediates and APIs, we provide the essential PNC-27 peptide for your research into targeted cancer therapies. Get a quote to buy today.
Applications of PNC-27 Peptide
Targeted Cancer Therapy
PNC-27 is pivotal in developing next-generation targeted cancer therapies, offering a precise mechanism for tumor cell destruction.
Oncology Research
Investigate the unique membrane-active properties of PNC-27 to understand its role in combating various forms of cancer and its potential in combination therapies.
Pharmaceutical Development
Utilize high-purity PNC-27 peptide, sourced from a trusted supplier, for the development and preclinical testing of novel anti-cancer drugs.
Mechanism of Action Studies
Explore the PNC-27 HDM-2 protein interaction and its resulting cascade effect, crucial for understanding peptide-based therapeutic strategies.